Guidelines for locoregional therapy in primary breast cancer in developing countries: The results of an expert panel at the 8th Annual Women's Cancer Initiative – Tata Memorial Hospital (WCI-TMH) Conference

Background: Limited guidelines exist for breast cancer management in developing countries. In this context, the Women's Cancer Initiative - Tata Memorial Hospital (WCI-TMH) organised its 8th Annual Conference to update guidelines in breast cancer. Materials and Methods: Appropriately formulated guideline questions on each topic and subtopic in the surgical, radiation and systemic management of primary breast cancer were developed by the scientific committee and shared with the guest faculty of the Conference. Majority of the questions had multiple choice answers. The opinion of the audience, comprising academic and community oncologists, was electronically cumulated, followed by focussed presentations by eminent national and international experts on each topic. The guidelines were finally developed through an expert panel that voted on each guideline question after all talks had been delivered and audience opinion elicited. Separate panels were constituted for locoregional and systemic therapy in primary breast cancer. Results: Based on the voting results of the expert panel, guidelines for locoregional therapy of breast cancer have been formulated. Voting patterns for each question are reported. Conclusions: The updated guidelines on locoregional management of primary breast cancer in the context of developing countries are presented in this article. These recommendations have been designed to allow centers in the developing world to improve the quality of care for breast cancer patients.

[1]  R. Dikshit,et al.  Single-injection depot progesterone before surgery and survival in women with operable breast cancer: a randomized controlled trial. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[2]  A. Derossis,et al.  Is Breast Cancer the Same Disease in Asian and Western Countries? , 2010, World Journal of Surgery.

[3]  R. Moineddin,et al.  Population-based longitudinal study of follow-up care for breast cancer survivors. , 2010, Journal of oncology practice.

[4]  Andrew Hanby,et al.  Comparative effectiveness of MRI in breast cancer (COMICE) trial: a randomised controlled trial , 2010, The Lancet.

[5]  L. Layfield,et al.  Initial margin status for invasive ductal carcinoma of the breast and subsequent identification of carcinoma in reexcision specimens. , 2010, Archives of pathology & laboratory medicine.

[6]  H. Bartelink,et al.  Toxicity at three years with and without irradiation of the internal mammary and medial supraclavicular lymph node chain in stage I to III breast cancer (EORTC trial 22922/10925) , 2010, Acta oncologica.

[7]  R. Badwe,et al.  Low axillary sampling in clinically node-negative operable breast cancer. , 2009, The National medical journal of India.

[8]  T. Julian,et al.  Accelerated partial breast irradiation consensus statement from the American Society for Radiation Oncology (ASTRO). , 2009, International journal of radiation oncology, biology, physics.

[9]  R. Gelber,et al.  Thresholds for therapies: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2009 , 2009, Annals of oncology : official journal of the European Society for Medical Oncology.

[10]  R. Sarin,et al.  Do all patients of breast carcinoma need 3-dimensional CT-based planning? A dosimetric study comparing different breast sizes. , 2009, Medical dosimetry : official journal of the American Association of Medical Dosimetrists.

[11]  A. Munshi,et al.  Factors influencing cosmetic outcome in breast conservation. , 2009, Clinical oncology (Royal College of Radiologists (Great Britain)).

[12]  J. Smallwood,et al.  Diagnosis and treatment of early breast cancer, including locally advanced disease—summary of NICE guidance , 2009, BMJ : British Medical Journal.

[13]  Krystyna Kiel,et al.  Breast cancer. Clinical practice guidelines in oncology. , 2009, Journal of the National Comprehensive Cancer Network : JNCCN.

[14]  C. Perez,et al.  Breast radiation therapy guideline implementation in low‐ and middle‐income countries , 2008, Cancer.

[15]  Les Irwig,et al.  Accuracy and surgical impact of magnetic resonance imaging in breast cancer staging: systematic review and meta-analysis in detection of multifocal and multicentric cancer. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[16]  J. Lang Placement of Radiopaque Clips for Tumor Localization in Patients Undergoing Neoadjuvant Chemotherapy and Breast Conservation Therapy , 2008 .

[17]  Wayne Beckham,et al.  A multicenter randomized trial of breast intensity-modulated radiation therapy to reduce acute radiation dermatitis. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[18]  J. Yarnold,et al.  The UK Standardisation of Breast Radiotherapy (START) Trial A of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial , 2008, The Lancet. Oncology.

[19]  J R Yarnold,et al.  The UK Standardisation of Breast Radiotherapy (START) Trial B of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial , 2008, The Lancet.

[20]  D. Lannin,et al.  Breast tattoos for planning surgery following neoadjuvant chemotherapy. , 2007, American journal of surgery.

[21]  S. Jolly,et al.  Intensity-modulated radiotherapy results in significant decrease in clinical toxicities compared with conventional wedge-based breast radiotherapy. , 2007, International journal of radiation oncology, biology, physics.

[22]  S. Leinster,et al.  A comparison of the cosmetic and psychological outcome of breast reconstruction, breast conserving surgery and mastectomy without reconstruction. , 2007, Breast.

[23]  S. Feigenberg,et al.  Long-term outcomes in breast cancer patients with ten or more positive axillary nodes treated with combined-modality therapy: the importance of radiation field selection. , 2007, International journal of radiation oncology, biology, physics.

[24]  C. Robles-Vidal,et al.  A 7 year experience with immediate breast reconstruction after skin sparing mastectomy for cancer. , 2007, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[25]  J. Overgaard,et al.  Is the benefit of postmastectomy irradiation limited to patients with four or more positive nodes, as recommended in international consensus reports? A subgroup analysis of the DBCG 82 b&c randomized trials. , 2007, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[26]  Richard Symonds-Tayler,et al.  Randomised trial of standard 2D radiotherapy (RT) versus intensity modulated radiotherapy (IMRT) in patients prescribed breast radiotherapy. , 2007, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[27]  M. Cronin,et al.  Gene expression and benefit of chemotherapy in women with node-negative, estrogen receptor-positive breast cancer. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[28]  Irene L Andrulis,et al.  HER2 and responsiveness of breast cancer to adjuvant chemotherapy. , 2006, The New England journal of medicine.

[29]  U. Chetty,et al.  Randomized multicenter trial of sentinel node biopsy versus standard axillary treatment in operable breast cancer: the ALMANAC Trial. , 2006, Journal of the National Cancer Institute.

[30]  Anthony Rhodes,et al.  American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer. , 2006, Archives of pathology & laboratory medicine.

[31]  R. Collins,et al.  Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials , 2005, The Lancet.

[32]  E. Berthelet,et al.  Selecting breast cancer patients with T1-T2 tumors and one to three positive axillary nodes at high postmastectomy locoregional recurrence risk for adjuvant radiotherapy. , 2005, International journal of radiation oncology, biology, physics.

[33]  L. Esserman Integration of imaging in the management of breast cancer. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[34]  T. Buchholz Locoregional radiation therapy in patients with high-risk breast cancer receiving adjuvant chemotherapy: 20-year results of the British Columbia randomized trial , 2005 .

[35]  Kathleen R Gundry,et al.  The application of breast MRI in staging and screening for breast cancer. , 2005, Oncology.

[36]  M. Cronin,et al.  A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer. , 2004, The New England journal of medicine.

[37]  F. Vicini,et al.  Use of pathologic factors to assist in establishing adequacy of excision before radiotherapy in patients treated with breast-conserving therapy. , 2004, International journal of radiation oncology, biology, physics.

[38]  H. Bartelink,et al.  The influence of the boost technique on local control in breast conserving treatment in the EORTC 'boost versus no boost' randomised trial. , 2004, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[39]  G. Hortobagyi,et al.  Breast conservation after neoadjuvant chemotherapy: the MD Anderson cancer center experience. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[40]  A. Luini,et al.  Intraoperative radiation therapy with electrons (ELIOT) in early-stage breast cancer. , 2003, Breast.

[41]  G. Hortobagyi,et al.  Neoadjuvant chemotherapy for breast carcinoma , 2003, Cancer.

[42]  G. O'leary,et al.  Cystic Cervical Metastases: Incidence and Diagnosis using Fine Needle Aspiration Biopsy , 2002, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.

[43]  I. Barillot,et al.  Recurrence rates after treatment of breast cancer with standard radiotherapy with or without additional radiation. , 2001, The New England journal of medicine.

[44]  N. Cascinelli,et al.  Axillary lymph node staging in breast cancer by 2-fluoro-2-deoxy-D-glucose-positron emission tomography: clinical evaluation and alternative management. , 2001, Journal of the National Cancer Institute.

[45]  S. Paik,et al.  HER2 and choice of adjuvant chemotherapy for invasive breast cancer: National Surgical Adjuvant Breast and Bowel Project Protocol B-15. , 2000, Journal of the National Cancer Institute.

[46]  S. Ciatto,et al.  Intensive vs Clinical Follow-up After Treatmentof Primary Breast Cancer: 10-Year Updateof a Randomized Trial , 1999 .

[47]  D. Schultz,et al.  Outcomes in breast cancer patients relative to margin status after treatment with breast-conserving surgery and radiation therapy: the University of Pennsylvania experience. , 1999, International journal of radiation oncology, biology, physics.

[48]  N. Le,et al.  Adjuvant radiotherapy and chemotherapy in node-positive premenopausal women with breast cancer. , 1997, The New England journal of medicine.

[49]  K. Zedeler,et al.  Postoperative Radiotherapy in High-Risk Premenopausal Women with Breast Cancer Who Receive Adjuvant Chemotherapy , 1997 .

[50]  R. Weichselbaum,et al.  Breast preservation in stage I and II carcinoma of the breast: The University of Chicago experience , 1996 .

[51]  D. Mant,et al.  Routine follow up of breast cancer in primary care: randomised trial , 1996, BMJ.

[52]  B. Haffty,et al.  Long-term outcome in patients with four or more positive lymph nodes treated with conservative surgery and radiation therapy. , 1996, International journal of radiation oncology, biology, physics.

[53]  R. Arriagada,et al.  Conservative treatment versus mastectomy in early breast cancer: patterns of failure with 15 years of follow-up data. Institut Gustave-Roussy Breast Cancer Group. , 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[54]  R. Steele,et al.  The Edinburgh randomized trial of axillary sampling or clearance after mastectomy , 1995, The British journal of surgery.

[55]  J E Mortimer,et al.  Factors influencing cosmetic results after conservation therapy for breast cancer. , 1995, International journal of radiation oncology, biology, physics.

[56]  I. Fentiman,et al.  Effect of menstrual phase on surgical treatment of breast cancer , 1994, The Lancet.

[57]  A. Luini,et al.  Effect of menstrual phase on surgical treatment of breast cancer , 1994, The Lancet.

[58]  R. Sarin,et al.  Therapeutic factors influencing the cosmetic outcome and late complications in the conservative management of early breast cancer. , 1993, International journal of radiation oncology, biology, physics.

[59]  C. Redmond,et al.  Pathologic findings from the national surgical adjuvant breast project protocol B‐06 10‐year pathologic and clinical prognostic discriminants , 1993, Cancer.

[60]  R. Senie,et al.  Timing of breast cancer excision during the menstrual cycle influences duration of disease-free survival. , 1991, Annals of internal medicine.

[61]  N. Barnard Diseases of the Breast , 1986 .

[62]  A. Luini,et al.  Local control and survival in early breast cancer: the Milan trial. , 1986, International journal of radiation oncology, biology, physics.

[63]  D. Goffinet,et al.  Breast edema following staging axillary node dissection in patients with breast carcinoma treated by radical radiotherapy , 1982, Cancer.

[64]  T. Eberlein Menstrual Cycle and Surgical Treatment of Breast Cancer: Findings From the NCCTG N9431 Study , 2011 .

[65]  F. Cardoso,et al.  Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. , 2011, Annals of oncology : official journal of the European Society for Medical Oncology.

[66]  Robert B Livingston,et al.  Prognostic and predictive value of the 21-gene recurrence score assay in postmenopausal women with node-positive, oestrogen-receptor-positive breast cancer on chemotherapy: a retrospective analysis of a randomised trial. , 2010, The Lancet. Oncology.

[67]  T. Julian,et al.  Primary outcome results of NSABP B-32, a randomized phase III clinical trial to compare sentinel node resection (SNR) to conventional axillary dissection (AD) in clinically node-negative breast cancer patients. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[68]  R. Sarin,et al.  Breast conservation treatment in women with locally advanced breast cancer - experience from a single centre. , 2006, International journal of surgery.

[69]  R. Prescott,et al.  Re: Breast-conserving surgery with or without radiotherapy: pooled-analysis for risks of ipsilateral breast tumor recurrence and mortality. , 2004, Journal of the National Cancer Institute.

[70]  J. Bryant,et al.  Pathobiology of preoperative chemotherapy: findings from the National Surgical Adjuvant Breast and Bowel (NSABP) protocol B-18. , 2002, Cancer.

[71]  Jong-Hyeon Jeong,et al.  Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. , 2002, The New England journal of medicine.

[72]  B. Haffty,et al.  Negative margin status improves local control in conservatively managed breast cancer patients. , 2000, The cancer journal from Scientific American.

[73]  S. Ciatto,et al.  Intensive vs clinical follow-up after treatment of primary breast cancer: 10-year update of a randomized trial. National Research Council Project on Breast Cancer Follow-up. , 1999, JAMA.

[74]  R. Orr The Impact of Prophylactic Axillary Node Dissection on Breast Cancer Survival—A Bayesian Meta-Analysis , 1999, Annals of surgical oncology.

[75]  A. Hanlon,et al.  A close or positive margin after mastectomy is not an indication for chest wall irradiation except in women aged fifty or younger. , 1998, International journal of radiation oncology, biology, physics.

[76]  W. McGuire,et al.  Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. , 1987, Science.